Lihui Qian

Title: Lihui Qian: Innovator in Medicinal Chemistry

Introduction

Lihui Qian is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific proteins related to cancer treatment. With a total of 14 patents, his work is paving the way for new therapeutic options.

Latest Patents

Lihui Qian's latest patents include innovative compounds with promising applications. One of his notable inventions is a spiro ring-containing quinazoline compound. This compound serves as an irreversible inhibitor for a K-Ras G12C mutant protein, which is crucial in preparing medications for combating Ras-related diseases, including tumors. Another significant patent involves aurora kinase inhibitors, which are novel pyridine compounds. These compounds are designed to be used in the preparation of anti-tumor drugs, showcasing Qian's commitment to advancing cancer therapies.

Career Highlights

Throughout his career, Lihui Qian has worked with various organizations, including Wigen Biomedicine Technology (Shanghai) Co., Ltd. His experience in these companies has allowed him to refine his expertise in drug development and medicinal chemistry.

Collaborations

Lihui Qian has collaborated with several professionals in his field, including Yuli Xie and Houxing Fan. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Lihui Qian's innovative work in medicinal chemistry and his focus on developing targeted therapies highlight his importance in the field. His contributions are expected to have a lasting impact on cancer treatment and drug development.